Finally, no correlation was observed between EGFR expression as assessed by IHC and presence of ‘classical’ mutations (P=0.732); conversely, the detection of ‘other’ variants was more frequent in patients with tumours, which did not express EGFR by IHC (28.9 vs 8.3%, P=0.036). Here, EGFR is linked to neoplasm.